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-Synuclein, an acidic neuronal protein of 140 amino
acids, is extremely heat-resistant and is natively un-
folded. Recent studies have demonstrated that
-synuclein has chaperone activity both in vitro and in
vivo, and that this activity is lost upon removing its
C-terminal acidic tail. However, the detailed mechanism
of the chaperone action of -synuclein remains un-
known. In this study, we investigated the molecular
mechanism of the chaperone action of -synuclein by
analyzing the roles of its N-terminal and C-terminal do-
mains. The N-terminal domain (residues 1–95) was found
to bind to substrate proteins to form high molecular
weight complexes, whereas the C-terminal acidic tail
(residues 96–140) appears to be primarily involved in
solubilizing the high molecular weight complexes. Be-
cause the substrate-binding domain and the solubilizing
domain for chaperone function are well separated in
-synuclein, the N-terminal-binding domain can be sub-
stituted by other proteins or peptides. Interestingly, the
resultant engineered chaperone proteins appeared to
display differential efficiency and specificity in terms of
the chaperone function, which depended upon the na-
ture of the binding domain. This finding implies that the
C-terminal acidic tail of -synuclein can be fused with
other proteins or peptides to engineer synthetic chaper-
ones for specific purposes.
-Synuclein, a major constituent of Lewy bodies in Parkin-
son’s disease, is an acidic neuronal protein that is composed of
140 amino acids (1–4). -Synuclein is extremely heat-resistant
and natively unfolded with an extended structure primarily
composed of random coils (5–7). -Synuclein consists of three
distinct regions (reviewed in Refs. 8–11). The N-terminal re-
gion of -synuclein contains KTKEGV repeats, which form
amphipathic -helixes that are reminiscent of the lipid-binding
domain of apolipoproteins (12). The central region of
-synuclein is composed of a very hydrophobic non-A compo-
nent of Alzheimer’s disease amyloid (NAC)1 peptide, and the
acidic C-terminal region of -synuclein is composed primarily
of acidic amino acids. Moreover, the amphipathic N-terminal
and the hydrophobic NAC regions are highly conserved be-
tween species, whereas the C-terminal region is highly variable
in size and in sequence (reviewed in Refs. 8–11). In addition to
-synuclein, the - and -synucleins and synoretin, members of
the synuclein family, have been identified in humans (1, 2,
13, 14).
-Synuclein has been suggested to be implicated in the
pathogenesis of Parkinson’s disease and related neurodegen-
erative disorders (reviewed in Refs. 8–11), and more recently,
to be an important regulatory component of vesicular transport
in neuronal cells (15). Moreover, -synuclein has been sug-
gested to function as a chaperone protein in vivo because it
appears to bind many cellular proteins (16–22). In particular,
-synuclein shares regions of homology with 14-3-3 proteins
(18), which are a family of ubiquitous cytoplasmic chaperones
(23), and binds to 14-3-3 proteins as well as to the ligands of
14-3-3 including PKC, BAD, and ERK (18). More importantly,
-synuclein is overexpressed under stress conditions (18). Re-
cently, the chaperone activity of -synuclein in vitro has been
demonstrated by two research groups (24, 25). Like other small
heat shock proteins (sHSPs), such as HSP25, HSP16, and
-crystallin (26–31), -synuclein is able to prevent the ther-
mally and chemically induced aggregation of substrate pro-
teins. The other synuclein family members, the - and
-synucleins, also appear to have this chaperone activity (24).
However, the detailed mechanism of the chaperone action of
-synuclein remains unknown. Interestingly, the chaperone
activity of -synuclein is lost upon removing its C-terminal
acidic tail (24), suggesting that the acidic tail plays an impor-
tant role in the molecular chaperone function. Furthermore,
conformational changes induced in -synuclein by environmen-
tal factors and its consequent aggregation abolish the chaper-
one activity of -synuclein (25), which suggests that the na-
tively unfolded conformation might be essential for the
substrate binding and subsequent stabilization by -synuclein.
The mechanism of the chaperone action of sHSPs, on the
other hand, is comparatively well understood. sHSPs protect
substrate proteins from stress (e.g. heat, chemicals, etc.) by
forming high molecular weight (HMW) complexes with par-
tially unfolded substrate proteins (27, 32–40). However, alone
sHSPs do not have the ability to protect enzymes from thermal
inactivation or to promote their functional refolding after de-
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naturation (31, 39, 41, 42), although a few exceptional cases
with marginal effects have been reported (30, 33, 43–46).
sHSPs have, therefore, been classified as “junior chaperones”
(47). sHSPs share many properties, for example, they have
extensive amino acid sequence similarity, and are found as
large, aggregated complexes of average mass 200–800 kDa
(reviewed in Refs. 48 and 49). The charged C-terminal domain
(also called the -crystallin domain) is well conserved in all
members of the sHSP family, whereas the hydrophobic N-
terminal domain is variable in length and sequence (49). The
N-terminal domain is known to play a crucial role in self-
assembly and thus contributes to chaperone activity (38, 50),
whereas the C-terminal domain is known to be crucial for
substrate protein binding and stabilization (51). In particular,
a 19-amino acid peptide derived from the C-terminal domain
has been shown to posses substantial chaperone activity (52).
The extended polar C-terminal tail (10–18 amino acid resi-
dues) is also important in the chaperone action of sHSPs, and
appears to fulfill many roles that are not completely under-
stood yet. First, the extended C-terminal tail of sHSPs is be-
lieved to function as a solubilizer (26, 53–56). Moreover, trun-
cation of the C-terminal tail results in a significant decrease in
the chaperone function and stability of sHSPs (55, 57). In some
sHSPs, the flexible C-terminal tail also appears to interact
directly with substrate proteins (29, 54). Furthermore, the
crystal structure of HSP16 reveals that the C-terminal tail is
also involved in the organization of the HSP oligomer (27, 28).
In this study, we investigated the molecular mechanism of
the chaperone action of -synuclein by analyzing the roles of
the N-terminal and C-terminal domains of -synuclein in the
molecular chaperone function. Unlike the sHSPs, the sub-
strate-binding domain and the solubilizing domain for chaper-
one function appeared to be well separated in -synuclein.
EXPERIMENTAL PROCEDURES
Materials—GSH, dithiothreitol (DTT), 1-chloro-2,4-dinitrobenzene,
and isopropyl--D-thiogalactopyranoside were purchased from Sigma.
Glutathione-Sepharose 4B was obtained from Peptron (Taejon, Korea).
Bovine plasma thrombin was supplied by Sigma. Leupeptin, pepstatin,
and phenylmethylsulfonyl fluoride were purchased from Roche Molec-
ular Biochemicals. Aldolase from rabbit muscle, insulin from the bovine
pancreas, lysozyme from chicken eggs, and luciferase from the firefly
(Photinus pyralis) were purchased from Sigma.
Purification of -Synuclein Deletion Mutants and GST-Synuclein
Fusion Proteins—-Synuclein was overexpressed in Escherchia coli and
the recombinant protein was purified to apparent homogeneity by tak-
ing advantage of the thermosolubility of the protein and by using
conventional column chromatography, as described previously (6, 58).
The GST protein encoded by the pGEX expression vector was purified
by affinity chromatography using glutathione-Sepharose 4B beads, and
further purified on an FPLC gel-filtration column. The GST--synuclein
fusion constructs, pGST-Syn-(61–140) and pGST-Syn-(96–140), were
generated by the PCR amplification of the -synuclein gene with spe-
cific primer sets containing the BglII and SalI restriction sites (59). The
GST-synuclein fusion constructs were transformed into the E. coli
strain, BL21(DE3), and the recombinant GST-synuclein fusion pro-
teins, GST-Syn-(61–140) and GST-Syn-(96–140), were purified by af-
finity chromatography using glutathione-Sepharose 4B beads. The
GST-synuclein fusion proteins were further purified on an FPLC gel-
filtration column. The -synuclein deletion mutants, Syn-(61–140) and
Syn-(96–140), were prepared from GST-Syn-(61–140) and GST-Syn-
(96–140), respectively, by thrombin digestion of the fusion proteins.
Construction of DHFR-Syn-(96–140) Expression Vector—The protein
coding region of dihydrofolate reductase (DHFR) was subcloned into an
E. coli expression vector, pRSETA, using BamHI and HindIII restric-
tion sites (pDHFR). The protein coding region of the C-terminal acidic
tail of -synuclein (residues 96–140) was amplified by PCR with the
5-oligonucleotide primer GCGCGGTACCAAGGACCAGTTGGGCAA-
GAATG containing the underlined KpnI restriction site and 3-oligonu-
cleotide primer GCGCGTCGACTTAGGCTTCAGGTTCGTAGT con-
taining the underlined SalI restriction site. The amplified DNAs were
gel purified, digested with appropriate enzymes, then ligated into the
pDHFR vector that had been digested with the appropriate restriction
enzymes and gel purified. All constructs were verified by DNA
sequencing.
Bacterial Expression and Purification of DHFR-Syn-(96–140)—The
DHFR-Syn-(96–140) fusion construct was transformed into the E. coli
strain BL21(DE3) for protein expression. The transformed bacteria
were grown in a LB medium with 0.1 mg/ml ampicillin at 37 °C to an
A600 of 0.8, then cultured for a further 4 h after being induced with 0.5
mM isopropyl--D-thiogalactopyranoside. The cells were harvested by
centrifugation at 10,000 rpm for 10 min, resuspended in phosphate-
buffered saline (PBS, pH 7.4), then disrupted by ultrasonication. After
removing the cell debris, the supernatants were loaded onto a nickel-
nitrilotriacetic acid column equilibrated with a loading buffer (50 mM
phosphate buffer (pH 8.0) containing 0.3 M NaCl and 10 mM imidazole).
After washing with the loading buffer, the protein was eluted with 250
mM imidazole in the same buffer. The DHFR-Syn-(96–140) fusion pro-
tein was further purified on an FPLC gel-filtration column. The protein
was concentrated and the buffer changed by Centricon (Amicon,
Beverly, MA).
Chaperone-like Activity Assay—The ability of chaperone proteins to
prevent heat-induced aggregation of substrate proteins (GST and aldol-
ase) was monitored as described previously (25). Briefly, substrate
proteins (0.2 mg/ml as a final concentration) in PBS (pH 7.4) were
incubated with each chaperone protein at 65 °C for specified times (see
figure legends) in a cuvette. Light scattering was then monitored at 360
nm as a function of time, using a spectrophotometer (Beckman DU-
650). The ability of the chaperone proteins to prevent chemically in-
duced substrate protein (insulin and lysozyme) aggregation was moni-
tored as described previously (24, 25). Substrate proteins (0.5 mg/ml as
a final concentration) in 10 mM phosphate buffer (pH 7.4) were incu-
bated with the indicated amounts of each chaperone protein at room
temperature (see figure legends). DTT was added, to a final concentra-
tion of 20 mM, to commence the denaturation and precipitation of
substrate proteins. Light scattering was then monitored at 360 nm
using a spectrophotometer (Beckman DU-650). In addition, luciferase
(0.1 mg/ml in PBS as a final concentration) was incubated with each
chaperone protein for 10 min at 65 °C in a cuvette, and light scattering
was monitored at 360 nm (Fig. 6B). For the insulin aggregation assay in
Fig. 6A, insulin alone (0.5 mg/ml as a final concentration in 10 mM
phosphate buffer, pH 7.4) or a mixture of insulin and GST-Syn-(96–140)
(0.5 mg/ml each as a final concentration) was preincubated for 5 min at
59 °C in a thermostatic cell holder, and this temperature was main-
tained during the chaperone assay. After adding 2 mM DTT as a final
concentration, the absorbance was measured at 360 nm as a function of
time.
Gel-filtration Chromatographic Analysis of the High Molecular
Weight Complexes—Individual solutions of each chaperone protein and
substrate protein (GST or aldolase, final concentration of 0.1–0.2 mg/ml
in PBS), or mixtures of chaperone and substrate proteins (final concen-
tration of 0.2–0.5 mg/ml chaperone protein with 0.1–0.2 mg/ml sub-
strate protein in PBS) were either heat treated (65 °C for 10 min) or not
heat-treated, and then centrifuged for 10 min at 13,000 rpm to remove
precipitated proteins. 500 l of each supernatant was loaded onto the
Superdex 75 HR 10/30 column (Amersham Biosciences) equilibrated in
PBS (pH 7.4), and the proteins were eluted at a flow rate of 1 ml/min at
room temperature. Fractions corresponding to each protein peak were
collected and analyzed in 12% SDS-polyacrylamide gels. To detect
-synuclein in the HMW complex, 25 l of each fraction was loaded into
a 12% SDS-polyacrylamide gel, transferred onto a polyvinylidene diflu-
oride membrane, and Western blotted with rabbit polyclonal anti--
synuclein antibodies.
GST Activity Assay—The enzymatic activity of GST was assayed
using a chromogenic substrate, 1-chloro-2,4-dinitrobenzene, as de-
scribed previously (60). The GST enzyme was added to the substrate
solution (1 mM GSH and 2 mM 1-chloro-2,4-dinitrobenzene in 0.1 M
phosphate buffer, pH 7.4) to a final concentration of 20 g/ml and
incubated at 37 °C for 10 min. Enzyme activity was measured as an
increased absorbance at 350 nm, corresponding to the maximum ab-
sorbance of 1-S-glutathionyl-2,4-dinitrobenzene, using the Spectramax
250 microplate reader (Molecular Devices, Menlo Park, CA).
Phosphatase Activity Assay—The catalytic activity of protein-tyro-
sine phosphatase-1B was assayed at 37 °C for 60 min in a reaction
mixture (0.2 ml) containing 10 mM p-nitrophenyl phosphate as sub-
strate. The buffer used was 20 mM Tris-HCl buffer (pH 7.4) containing
0.15 M NaCl, 1 mM EDTA, and 2 mM DTT. The reaction was initiated by
adding enzyme and quenched after 60 min by the addition of 1 ml of 1
N NaOH. The amount of p-nitrophenol released was determined by
measuring the absorbance at 405 nm.
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RESULTS
The C-terminal Acidic Tail Is Necessary, but Insufficient for
the Chaperone Activity of -Synuclein—Previous studies have
shown that -synuclein has chaperone activity in vitro (24, 25).
Like other small molecular chaperone proteins, -synuclein
was able to protect a variety of proteins from stress-induced
aggregation. Interestingly, the chaperone activity of
-synuclein was completely lost upon removing its C-terminal
acidic tail (24), which suggests that the acidic tail was critical
for its chaperone activity. We first asked whether the acidic tail
was sufficient to have the chaperone activity. To address this
question, we constructed two deletion mutants encoding either
the acidic tail only (residues 96–140, Syn-(96–140)) or the NAC
region plus the acidic tail (residues 61–140, Syn-(61–140)), and
compared their chaperone activities with that of wild type
-synuclein. The effect of the deletion mutants on the heat-
induced precipitation of substrate proteins was first investi-
gated by using the conventional chaperone activity assay. As
shown in Fig. 1A, the C-terminal acidic tail alone (Syn-(96–
140)) did not protect GST from heat-induced precipitation (Fig.
1A, line 4), whereas Syn-(61–140) containing the NAC region
and the acidic tail appeared to protect GST from heat-induced
precipitation almost as effectively as the wild type -synuclein
(Fig. 1A, lines 3 and 2, respectively). This result suggests that
Syn-(61–140) has all the units necessary for chaperone activity.
Similar results were obtained when aldolase was used as the
substrate for the chaperone activity assay (Fig. 1B).
We next compared the chaperone activity of the -synuclein
deletion mutants by measuring the chemically induced aggre-
gation of insulin and lysozyme (Fig. 1, C and D). Consistent
with the results obtained from the heat-induced precipitation
assay, Syn-(96–140) did not protect the substrate proteins from
DTT-induced precipitation (Fig. 1C, line 6). On the other hand,
Syn-(61–140) effectively protected the substrate proteins from
DTT-induced precipitation (Fig. 1, C, lines 3–5, and D, lines 3
and 4). Interestingly, Syn-(61–140) appeared to be much more
efficient than wild type -synuclein (Figs. 1, C and D, line 2) in
terms of protecting the substrate proteins from DTT-induced
precipitation. This aggregation was almost completely sup-
pressed at an insulin to chaperone weight ratio of 1:0.5, corre-
sponding to a stoichiometric ratio of 1:0.3 (Fig. 1C, line 4).
Syn-(61–140) also appeared to protect lysozyme from DTT-
induced aggregation at a substoichiometric ratio (Fig. 1D, line
4). Syn-(61–140), Syn-(96–140), and wild type -synuclein
alone did not precipitate under these conditions (data not
shown). These results indicate that the C-terminal acidic tail of
-synuclein was necessary, but not sufficient for the chaperone
activity of -synuclein, and also suggest that the N-terminal
region (residues 1–95) of -synuclein may determine the effi-
ciency of the chaperone function.
The N-terminal Region Mediates Substrate Protein Bind-
ing—Small molecular chaperones, such as small heat shock
proteins, -crystallin, tubulin, and clusterin, prevent protein
precipitation by forming soluble HMW complexes (27, 32–40).
We first confirmed that -synuclein also acts in this way to
prevent protein precipitation, and then investigated which re-
FIG. 1. Chaperone-like activity of -synuclein and its deletion mutants. A and B, thermally induced aggregation assay. A, aggregation
curves of GST (0.2 mg/ml in PBS, pH 7.4) at 65 °C in the absence and presence of -synuclein deletion mutants. Lines: 1, GST alone; 2, GST 
-synuclein (0.2 mg/ml); 3, GST  Syn-(61–140) (0.2 mg/ml); 4, GST  Syn-(96–140) (0.2 mg/ml); 5, -synuclein (0.2 mg/ml) alone; 6, Syn-(61–140)
(0.2 mg/ml) alone; 7, Syn-(96–140) (0.2 mg/ml) alone. B, aggregation curves of aldolase (0.2 mg/ml in PBS, pH 7.4) at 65 °C in the absence and
presence of -synuclein deletion mutants. Lines: 1, aldolase alone; 2, aldolase  -synuclein (0.2 mg/ml); 3, aldolase  Syn-(61–140) (0.2 mg/ml);
4, aldolase  Syn-(96–140) (0.2 mg/ml). C and D, DTT-induced aggregation assay. C, aggregation curves of insulin (0.5 mg/ml in 10 mM phosphate
buffer, pH 7.4) induced with 20 mM DTT in the absence and presence of -synuclein deletion mutants. Lines: 1, insulin alone; 2, insulin 
-synuclein (0.5 mg/ml); 3–5, insulin  Syn-(61–140) (1:1, 1:0.5, and 1:0.1, w/w, respectively); 6, insulin  Syn-(96–140) (0.5 mg/ml). D, aggregation
curves of lysozyme (0.5 mg/ml in 10 mM phosphate buffer, pH 7.4) induced with 20 mM DTT in the absence and presence of -synuclein deletion
mutants. Lines: 1, lysozyme alone; 2, lysozyme  -synuclein (1:1, w/w); 3 and 4, lysozyme  Syn-(61–140) (1:1 and 1:0.2, w/w, respectively).
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gion of -synuclein was critical for substrate protein binding
(Fig. 2). The substrate protein (GST) was incubated with wild
type -synuclein or its C-terminal fragment (Syn-(96–140)) for
10 min at 65 °C and the protein mixtures were purified on a
FPLC gel-filtration column. Each peak fraction was then ana-
lyzed on SDS-polyacrylamide gels. As expected, -synuclein
formed a soluble HMW complex with the substrate protein
(Fig. 2A). Syn-(61–140) also appeared to form a HMW complex
with GST (data not shown). In contrast, the C-terminal acidic
tail of -synuclein (Syn-(96–140)) did not form a HMW complex
(Fig. 2B), which suggested that substrate protein binding may
be mediated by the N-terminal region of -synuclein. Unlike
other small molecular chaperone proteins, however, the HMW
complex formed between -synuclein and GST contained only a
trace amount of -synuclein, which was detected by immuno-
blotting (Fig. 2A, f). The immunoreactivity of -synuclein was
only detected in fractions corresponding to the HMW complex,
indicating that these HMW forms of -synuclein were not con-
taminated by the aggregates. A similar phenomenon was ob-
served when other substrate proteins were used (data not
shown). Previous studies have shown that Syn-(1–97) precipi-
tates upon heat treatment and does not have the chaperone
activity (24). In addition, NAC and the C-terminal truncated
-synuclein have been shown to aggregate faster than the
full-length -synuclein (61–64). Taken together, it is highly
likely that the N-terminal region of -synuclein functions as a
binding domain for substrate proteins and that the C-terminal
acidic tail functions as a solubilizing domain for the HMW
complexes and for -synuclein itself.
The Binding Domain Can Be Substituted by Other Proteins—
This study shows that the binding domain and solubilizing
domain were structurally distinct in -synuclein. Based on this
finding, we hypothesized that the binding domain could be
substituted by other proteins, because the binding domain of
molecular chaperone proteins was not likely to be specific for
individual substrate proteins. The chaperone activity of Syn-
(61–140) (Fig. 1) supports this idea. To prove this hypothesis
further, we constructed a GST-synuclein fusion protein, GST-
Syn-(96–140), containing the acidic tail of -synuclein at the C
terminus of GST. Surprisingly, GST-Syn-(96–140) prevented
GST and aldolase from heat-induced precipitation (Fig. 3, A
and B). Furthermore, GST-Syn-(96–140) appeared to be a more
efficient chaperone protein than wild type -synuclein and
Syn-(61–140) (Figs. 1, A and B, 3, A and B), and almost com-
pletely prevented GST and aldolase from heat-induced precip-
itation when they were incubated at a ratio of 1:1 (w/w) (Fig. 3,
FIG. 2. The N-terminal region of -synuclein mediates substrate protein binding. A, FPLC gel-filtration chromatography (a–d) and
SDS-PAGE (e and f) analysis of the HMW complex of wild type -synuclein and GST. Protein samples (500 l) were loaded onto the Superdex 75
HR column (Amersham Biosciences) equilibrated in PBS, and eluted at a flow rate of 1 ml/min at room temperature. a, GST (0.1 mg/ml). b,
-synuclein (0.5 mg/ml). -Synuclein incubated at 65 °C for 10 min was eluted at the same position (data not shown). c, GST (0.1 mg/ml) 
-synuclein (0.5 mg/ml) were mixed and loaded onto the column. d, GST (0.1 mg/ml)  -synuclein (0.5 mg/ml) were mixed and incubated for 10
min at 65 °C and then loaded onto the column. e, SDS-PAGE analysis of the -synucleinGST complex. The peak fractions numbered in a–d were
separated on a 12% SDS-polyacrylamide gel and stained with Coomassie Brilliant Blue R-250. f, Western blot was performed to detect -synuclein
in the HMW complex (containing peak fractions 3–5 from d). B, FPLC gel-filtration chromatography (a–d) and SDS-PAGE (e) analysis of the
Syn-(96–140)GST complex. a, GST (0.2 mg/ml). b, Syn-(96–140) (0.2 mg/ml). c, GST (0.2 mg/ml)  Syn-(96–140) (0.2 mg/ml) were mixed and
loaded onto the column. d, GST (0.2 mg/ml)  Syn-(96–140) (0.2 mg/ml) were mixed and incubated for 10 min at 65 °C and then loaded onto the
column. The arrow indicates the expected position for GST. e, SDS-PAGE analysis of the Syn-(96–140)GST complex. The peak fractions numbered
in a–d were separated on a 12% SDS-polyacrylamide gel and stained with Coomassie Brilliant Blue R-250. Lanes: 1, Syn-(96–140); 2, GST; 3, peak
3 from d; 4, pellet fraction obtained after incubating the Syn-(96–140)/GST mixture for 10 min at 65 °C.
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A, line 4, and B, line 4). However, GST-Syn-(96–140) was not as
effective as -synuclein at protecting proteins from chemically
induced precipitation (Fig. 3, C and D). In particular, GST-Syn-
(96–140) did not prevent lysozyme from DTT-induced precipi-
tation, although it slightly alleviated the DTT-induced precip-
itation of insulin.
Like other small molecular chaperone proteins, GST-Syn-
(96–140) formed a HMW complex when incubated with aldol-
ase, a substrate protein, for 10 min at 65 °C (Fig. 4). GST-Syn-
(96–140) also formed a HMW complex with GST when the
proteins were co-incubated at 65 °C (data not shown). Unlike
-synuclein, GST-Syn-(96–140) appeared to form HMW com-
plexes with a stoichiometric ratio (Fig. 4, d and f, lanes 3–6),
which suggests that it interacts with substrate proteins in a
similar way to the sHSPs. These results indicate that the
binding domain of -synuclein can be substituted with another
protein or peptide and the resultant engineered protein func-
tions as a molecular chaperone with a different efficiency and
specificity.
DHFR-Syn-(96–140) Also Has Chaperone Activity—To ad-
dress whether any proteins containing the acidic tail of
-synuclein have chaperone activity, we constructed a DHFR-
synuclein fusion protein, DHFR-Syn-(96–140), which contains
the acidic tail of -synuclein at the C terminus. Interestingly,
DHFR-Syn-(96–140) was extremely heat resistant, whereas
DHFR was so heat-labile that it easily precipitated by thermal
stress (data not shown). Similar phenomenon has been ob-
served when GST was fused with the acidic tail of -synuclein
(59). We next examined the chaperone activity of DHFR-Syn-
(96–140). As shown in Fig. 5, DHFR-Syn-(96–140) effectively
protects aldolase from heat-induced aggregation, indicating
that the fusion protein functions as a molecular chaperone.
DHFR-Syn-(96–140) also appeared to prevent GST from heat-
induced precipitation (data not shown). Therefore, it is highly
likely that the C-terminal acidic tail of -synuclein can be used
to engineer synthetic chaperones.
The Binding Domain Determines the Efficiency and Specific-
ity of Chaperone Function—Our data show that engineered
chaperone proteins (Syn-(61–140), GST-Syn-(96–140), and
DHFR-Syn-(96–140)) containing the acidic tail of -synuclein
as a solubilizing domain display different chaperone activities
and substrate specificities, and that these differences might
originate from the intrinsic properties of the binding domain.
For example, Syn-(61–140) appeared to be a better chaperone
than wild type -synuclein at preventing the DTT-induced
precipitation of substrate proteins (Fig. 1, C and D). Further-
more, GST-Syn-(96–140) appeared to inhibit the heat-induced
precipitation of substrate proteins far more so than wild type
-synuclein or Syn-(61–140) (Fig. 3, A and B), but to only
weakly suppress the DTT-induced precipitation of substrate
proteins (Fig. 3, C and D). To confirm the notion that the
binding domain might determine the efficiency and specificity
of the chaperone function, we induced conformational changes
in GST-Syn-(96–140) by heating, and examined changes in its
chaperone-like activity during the DTT-induced aggregation of
insulin. The conformation of GST-Syn-(96–140) was irrevers-
ibly changed at high temperatures with a melting temperature
(Tm) of 62 °C (59), but insulin alone did not precipitate at this
FIG. 3. Chaperone-like activity of GST-Syn-(96–140). A and B, thermally induced aggregation assay. A, aggregation curves of GST (0.2
mg/ml in PBS, pH 7.4) at 65 °C in the absence and presence of GST-Syn-(96–140). Lines: 1, GST alone; 2–4, GST  GST-Syn-(96–140) (1:0.1, 1:0.5,
and 1:1, w/w, respectively); 5, GST-Syn-(96–140) (0.2 mg/ml) alone. B, aggregation curves of aldolase (0.2 mg/ml in PBS, pH 7.4) at 65 °C in the
absence and presence of GST-Syn-(96–140). Lines: 1, aldolase alone; 2–4, aldolase  GST-Syn-(96–140) (1:0.2, 1:0.5, and 1:1, w/w, respectively).
C and D, DTT-induced aggregation assay. C, aggregation curves of insulin (0.5 mg/ml in 10 mM phosphate buffer, pH 7.4) induced with 20 mM DTT
in the absence and presence of GST-Syn-(96–140). Lines: 1, insulin alone; 2–4, insulin  GST-Syn-(96–140) (1:1, 1:3, and 1:5, w/w, respectively);
5, GST-Syn-(96–140) (0.5 mg/ml) alone. D, aggregation curves of lysozyme (0.5 mg/ml in 10 mM phosphate buffer, pH 7.4) induced with 20 mM DTT
in the absence and presence of GST-Syn-(96–140). Lines: 1, lysozyme alone; 2 and 3, insulin  GST-Syn-(96–140) (1:1 and 1:3, w/w, respectively).
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temperature (data not shown). Interestingly, the chaperone
activity of GST-Syn-(96–140) in the DTT-induced aggregation
of insulin was significantly improved at 59 °C (Fig. 6A) com-
pared with the case at room temperature (Fig. 3C), suggesting
that the efficiency of its chaperone action was affected by con-
formational changes in its N-terminal substrate-binding do-
main (GST domain in this case). In addition, we found that
GST-Syn-(96–140) did not protect the heat-induced aggrega-
tion of luciferase, whereas -synuclein and Syn-(61–140) effec-
tively prevented this aggregation (Fig. 6B). Therefore, it seems
highly likely that the binding domain determines the efficiency
and specificity of the chaperone function.
GST-Syn-(96–140) Does Not Protect Enzymes from Heat-in-
duced Inactivation—Small molecular chaperone proteins are
generally known to be inefficient at preventing the thermal
inactivation of enzymes (31, 39–42, 65), although some small
molecular chaperone proteins are reported to have a marginal
potential to protect certain enzymes from thermal inactivation
(30, 33, 43–47). Previously, we showed that -synuclein did not
protect GST enzyme from heat-induced inactivation (25). To
investigate whether GST-Syn-(96–140) was able to protect en-
zymes from thermal inactivation, the thermostabilities of GST
and protein-tyrosine phosphatase-1B were measured using
thermal inactivation curves in the presence and in the absence
of the GST-Syn-(96–140) (Fig. 7). The thermal inactivation
curves were used to determine the T50 values, the tempera-
FIG. 4. FPLC gel-filtration chromatography (a–e) and SDS-
PAGE (f) analysis of the HMW complex between GST-Syn-(96–140)
and aldolase. Protein samples (500 l) were loaded onto the Superdex 75
HR column (Amersham Biosciences) equilibrated in PBS, and eluted at a
flow rate of 1 ml/min at room temperature. a, aldolase (0.2 mg/ml). b,
GST-Syn-(96–140) (0.2 mg/ml). c, aldolase (0.2 mg/ml) and GST-Syn-(96–
140) (0.2 mg/ml) were mixed and loaded onto the column. d, aldolase (0.2
mg/ml) and GST-Syn-(96–140) (0.2 mg/ml) were mixed and incubated for
10 min at 65 °C and then loaded onto the column. e, GST-Syn-(96–140)
(0.2 mg/ml) were incubated for 10 min at 65 °C and then loaded onto the
column. f, SDS-PAGE analysis of the HMW complex. The peak fractions
numbered in a–d were separated on a 12% SDS-polyacrylamide gel and
stained with Coomassie Brilliant Blue R-250.
FIG. 5. Chaperone-like activity of DHFR-Syn-(96–140). Aggre-
gation curves of aldolase (0.2 mg/ml in PBS, pH 7.4) at 65 °C in the
absence and presence of DHFR-Syn-(96–140). Lines: 1, aldolase alone;
2–4, aldolase  DHFR-Syn-(96–140) (1:0.5, 1:1, and 1:2, w/w, respec-
tively); 5, DHFR-Syn-(96–140) (0.2 mg/ml) alone.
FIG. 6. Substrate specificity of GST-Syn-(96–140) as a molecu-
lar chaperone. A, temperature effect on the chaperone-like activity of
GST-Syn-(96–140). Protein mixtures were preincubated for 5 min at
59 °C, then 2 mM DTT was added to induce the aggregation of insulin,
and mixtures were then placed on a thermostatic cell holder. Lines: 1,
insulin (0.5 mg/ml) alone; 2, insulin  GST-Syn-(96–140) (1:1, w/w); 3,
insulin  GST-Syn-(96–140) (1:0.5, w/w); and 4, GST-Syn-(96–140) (0.5
mg/ml) alone. B, GST-Syn-(96–140) did not protect luciferase from
heat-induced aggregation. Protein mixtures were incubated for 10 min
at 65 °C, and light scattering was measured at 360 nm. Graphs: 1,
luciferase (0.1 mg/ml) alone at room temperature; 2, luciferase (0.1
mg/ml) alone at 65 °C; 3, luciferase  GST-Syn-(96–140) (1:1, w/w) at
65 °C; 4, luciferase  Syn-(61–140) (1:1, w/w) at 65 °C.
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tures at which 50% of initial enzymatic activity was lost after
heat treatment. As shown in Fig. 7, T50 values of GST and
protein-tyrosine phosphatase-1B appeared to be similar in the
presence and absence of the chaperone protein. This suggests
that GST-Syn-(96–140) was incapable of protecting enzymes
from thermal inactivation, although it can prevent the enzymes
from thermal aggregation.
DISCUSSION
-Synuclein has been suggested to work as a chaperone
protein in mammalian cells (18), and recent studies have
shown that -synuclein acts as a chaperone in vitro, and that
the C-terminal truncated form of -synuclein (Syn-(1–97)) has
no chaperone activity (24, 25). In this study, we have shown
that the C-terminal acidic tail itself (Syn-(96–140)) does not
interact with the substrate protein and consequently does not
protect the protein from stress-induced aggregation. However,
in common with wild type -synuclein, an N-terminal trun-
cated form of -synuclein (Syn-(61–140)) binds the substrate
protein and retains the chaperone activity, albeit with a
slightly different efficiency and substrate specificity. This indi-
cates that the N-terminal region of -synuclein (residues 1–95)
plays a critical role in substrate protein binding, and that the
C-terminal acidic tail might function to solubilize the HMW
complex (Fig. 8). Interestingly, the N-terminal-binding domain
can be substituted by other proteins or peptides, such as GST,
DHFR, or NAC peptide (Fig. 8), and the resulting fusion pro-
teins were also found to have chaperone activity. More impor-
tantly, the synthetic chaperone proteins appear to display dif-
ferential chaperone activity in terms of their efficiencies and
substrate specificities (Figs. 1, 3, and 6).
The N-terminal part of -synuclein (residues 1–61) is homol-
ogous to the chaperone protein 14-3-3 (18). Consequently,
-synuclein and 14-3-3 bind to many of the same proteins, such
as PKC, BAD, ERK, and tyrosine hydroxylase (18, 22).
-Synuclein was also able to bind to 14-3-3, tau protein, tubu-
lin, synphilin-1, and phospholipase D2 with high specificity and
affinity (16–21). Furthermore, expression of -synuclein was
greatly increased in 293 HEK cells under stress conditions (18).
Based on these observations, it has been suggested that
-synuclein functions as a chaperone protein in vivo (18). This
hypothesis has been supported by the in vitro chaperone activ-
ity of -synuclein reported recently (24, 25). However,
-synuclein appears to be a much weaker chaperone than
HSP27 in preventing thermally induced aggregation of alcohol
dehydrogenase and chemically induced aggregation of insulin
in vitro (24). Our data also indicate that -synuclein can protect
target proteins from stress-induced aggregation only at a sub-
stoichiometric ratio (Fig. 1). Taken together, it seems likely
that -synuclein at least acts as a chaperone in vivo for specific
target proteins, like the case of the 14-3-3 chaperone. Potential
target proteins may include those proteins that are known to
associate with -synuclein.
Most chaperone proteins have a flexible, hydrophilic tail that
is important for proper chaperone function. For example,
GroEL is known to have flexible N- and C-terminal tails, which
protrude into the central cavity of the molecule (66). SecB, a
bacterial chaperone involved in protein export, has been pro-
posed to have a highly flexible C-terminal region that is in-
volved in binding to non-native proteins (67). X-ray crystallo-
graphic and NMR spectroscopic analyses have shown that
sHSPs, such as HSP25, HSP16, and -crystallin, contain a
flexible C-terminal extension (27–29, 68). Other small molecu-
FIG. 7. Thermal inactivation curves of GST (A) and protein-
tyrosine phosphatase-1B (B) in the presence and absence of
GST-Syn-(96–140). Activity is expressed as a percentage of initial
activity. Values are the means of three independent experiments, and
the standard deviation is shown as bars. The protein samples were
incubated for 5 min at the indicated temperatures, and the enzymatic
activities were measured as described under “Experimental Proce-
dures” at 37 °C.
FIG. 8. Distinct roles of the N-terminal-binding domain and
the C-terminal-solubilizing domain of -synuclein in its molec-
ular chaperone function. Proteins containing both the binding do-
main and the solubilizing domain exhibit chaperone-like activity.
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lar chaperones, such as clusterin and tubulin, are also known
to have a flexible tail at the C terminus (65, 69). These flexible,
hydrophilic tails have been suggested to play a critical role in
substrate and chaperone protein interactions, and to function
as a solubilizer (26, 53–56). In fact, a mutation in the C-
terminal end or a deletion of the C-terminal end caused a
significant decrease in the chaperone activity of -crystallin
(55, 57). Tubulin also lost its chaperone-like activity when the
C-terminal acidic tail was removed by protease digestion (69).
A previous study showed that the removal of the C-terminal
acidic tail of -synuclein abolished its chaperone activity (24).
Our present data indicate that the C-terminal acidic tail was
indeed necessary, but not sufficient for the chaperone function
of -synuclein. The acidic tail itself does not have chaperone
activity, and does not appear to interact with the substrate
protein. It is highly likely that the role of the introduced acidic
tail is to increase protein solubility by electrostatic repulsions.
It is well documented that the solubility of a protein is approx-
imately proportional to the square of the net charge on the
protein (70). In fact, introducing the acidic tail greatly de-
creases the pI and hydropathy values of the fusion protein (59),
and the C-terminal truncated -synuclein mutants are found to
aggregate faster than the full-length -synuclein under the
same conditions (61–64). Furthermore, fusion proteins con-
taining the -synuclein acidic tail (GST-Syn-(96–140) and
DHFR-Syn-(96–140)) has chaperone-like activity, which sug-
gests that a possible role of the acidic tail in chaperone function
might involve solubilizing the substrate-chaperone complex, as
well as the chaperone protein itself.
We have shown that the N-terminal region of -synuclein
binds the substrate protein forming a soluble HMW complex
(Fig. 2). The GST-Syn-(96–140) fusion protein also appears to
form such a HMW complex, suggesting that the GST domain
interacts with the substrate protein (Fig. 4). Interestingly,
however, the efficiency of the chaperone function of GST-Syn-
(96–140) differs from that of wild type -synuclein. GST-Syn-
(96–140) appeared to be more efficient than -synuclein at
preventing GST and aldolase from heat-induced aggregation,
but less efficient at preventing DTT-induced aggregation of
insulin and lysozyme (Fig. 3). In addition, an N-terminal trun-
cated form of -synuclein (Syn-(61–140)) appeared to be more
efficient than wild type -synuclein at preventing proteins from
DTT-induced aggregation (Fig. 1). These results strongly sug-
gest that the N-terminal-binding domain plays a crucial role in
the efficiency of the chaperone function. This idea is further
supported by the observation that GST-Syn-(96–140) effec-
tively prevents insulin from DTT-induced aggregation at ele-
vated temperatures (Fig. 6A). At the elevated temperatures,
the tertiary structure of GST must be changed and the per-
turbed structure seems to become more favorable for substrate
protein binding. Furthermore, GST-Syn-(96–140) does not pro-
tect luciferase from heat-induced aggregation (Fig. 6B), al-
though it effectively protects GST and aldolase (Fig. 3, A and B)
and -synuclein was able to protect all these molecules from
heat-induced aggregation (Figs. 1, A and B, and 6B). These
results suggest that the chaperone function of GST-Syn-(96–
140) was much more specific/limited than that of -synuclein.
Taken together, our data demonstrate that the N-terminal-
binding domain governs the efficiency and the substrate spec-
ificity of the chaperone proteins.
The chaperone action of sHSPs requires a common step of
substrate protein binding and a subsequent step of solubilizing
the HMW complex of chaperone and substrate protein (27,
32–40). The present study demonstrates that -synuclein func-
tions in the same manner as the sHSPs; -synuclein prevents
protein aggregation by binding substrate protein and subse-
quently by solubilizing the HMW complex. Furthermore, our
results show that the substrate-binding domain and the solu-
bilizing domain are clearly separated in -synuclein; the N-
terminal region (residues 1–95) binds the substrate protein and
the C-terminal acidic tail (residues 96–140) solubilizes the
HMW complex. Unlike -synuclein, however, sHSPs do not
appear to have well separated substrate-binding and -solubi-
lizing domains. In the case of sHSPs, the hydrophobic and the
charged/hydrophilic regions are scattered through the N- and
C-terminal domains (49). sHSPs also have short, hydrophilic
extensions at the C terminus (10–15 residues), but these C-
terminal extensions play a significant role in substrate binding,
as well as in solubilizing the HMW complexes (54, 56). Fur-
thermore, C-terminal truncated forms of sHSPs still retain the
chaperone activity, although the chaperone activity is some-
what reduced and limited in some cases (38, 51, 55, 57). This
further suggests that the amino acid residues responsible for
substrate binding and solubilizing sHSP-based HMW com-
plexes are scattered through the whole of the sHSP molecules.
The chaperone activity of sHSPs toward DTT- and UV-in-
duced protein aggregation is enhanced as the temperature
increases, because the conformation of sHSPs is presumably
perturbed and consequently hydrophobic surfaces are more
exposed at the higher temperatures (40, 71–76). A similar
temperature-dependent interaction between GroEL and sub-
strate protein has been reported (77). The chaperone-like ac-
tivity of tubulin also becomes more pronounced as temperature
increases (69). Previously, we reported that preheating
-synuclein, which is believed to reorganize the molecular sur-
face of the protein, increases its chaperone activity (25). In this
study, we demonstrated that GST-Syn-(96–140) more effi-
ciently protects insulin from DTT-induced aggregation at 59 °C
than at room temperature (Fig. 6A). Therefore, as has been
observed for other molecular chaperone proteins, temperature-
induced structural perturbation of the GST domain (substrate-
binding domain) seems to be responsible for the increased
chaperone-like activity observed at higher temperatures.
The list of the new small molecular chaperones discovered is
increasing quite steadily, and recently tubulin, clusterin, and
nucleolar protein B23 have been added as new members (65,
69, 78). Tubulin also has a C-terminal acidic tail and the
removal of this tail abolishes its chaperone-like activity (69).
Clusterin contains three putative amphipathic -helical re-
gions that might mediate interaction with hydrophobic mole-
cules (65), and nucleolar protein B23 has been reported to have
chaperone-like activity through a similar mechanism (78).
These chaperone proteins (tubulin, clusterin, and B23) have no
amino acid sequence similarity with either sHSPs or
-synuclein. Therefore, it would be interesting to compare de-
tailed molecular mechanisms of the chaperone action mediated
by these molecules with those of -synuclein and sHSPs.
In summary, the results of this study indicate that the N-
terminal region of -synuclein binds substrate protein and
forms a HMW complex, whereas the C-terminal acidic tail
solubilizes the HMW complex during the chaperone action.
Because the substrate-binding domain and the solubilizing do-
main are well separated in -synuclein, the N-terminal-binding
domain can be substituted with other proteins or peptides.
Moreover, the resulting engineered chaperone proteins appear
to display different efficiencies and substrate specificities in
terms of the chaperone function. This implies that the C-ter-
minal acidic tail of -synuclein can be utilized to engineer
synthetic chaperones for specific purposes simply by fusing the
acidic tail with other proteins or peptides. Such specifically
designed chaperone proteins would be useful for stabilizing
target proteins both in vitro and in vivo.
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